ScholarWorks@Korea University: Chun, Byung Chul

Detailed Information

Chun, Byung Chul (천병철)

College of Medicine (Department of Medical Science)

Research Area

Tel 02-2286-1169
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Korea:14||COVID19:12||Influenza:6||SARSCoV2:6||Epidemiology:6||Vaccination:5||Surveillance:5||Incidence:5||avian influenza:4||epidemiology:3||Antibiotic resistance:3||spatial analyses:3||Disease outbreaks:3||South Korea:3||Bacterial:2||Alcohol:2||HPAI:2||Aged:2||Hand washing:2||Cirrhosis:2||National Immunization Program:2||Coronavirus:2||Prevention:2||Medical education:2||Outbreak:2||Risk factors:2||Hepatocellular carcinoma:2||coronavirus:2||risk factors:2||Klebsiella pneumoniae:2||Vaccine:2||highly pathogenic avian influenza:2||Mortality:2||Infection control:2||Infection:2||Drug resistance:2||Bioterrorism:2||Questionnaire:2||Pneumococcal infections:2||Public health:2||pharmacovigilance:2||mortality:2||poultry:2||cluster analysis:2||Antimicrobial utilization:2||Hepatitis B virus:2||Hepatitis A:2||Crosssectional study:2||Standardization:2||Methicillinresistant Staphylococcus aureus (MRSA):2||Serial Interval:1||simulation:1||Korea Community Health Survey:1||Flipped classroom:1||Vaccines:1||Hearing disability:1||Screening test:1||Disease Outbreaks:1||Latent Tuberculosis:1||Coronavirus infections:1||Lower urinary tract symptoms:1||Selfconcept:1||influenza:1||Otitis media:1||Healthrelated college:1||genotype:1||Korean:1||Public policy:1||Sanitary:1||Cost analysis:1||Emergency preparedness:1||2019 novel coronavirus disease:1||adenoviruses:1||Timeseries:1||FluNet:1||Chicken:1||species distribution model:1||social distancing:1||risk assessment:1||FETP:1||climate factors:1||acute cardiovascular complications:1||vasculitis:1||drugrelated side effects and adverse reactions:1||Vaccine effectiveness:1||Vaccine Effectiveness:1||Gender equity:1||epidemic curve:1||Quadrivalent:1||Casecontrol study:1||Poultry:1||Neonates:1||Crosscorrelation:1||worker:1||Potablewater system:1||Adolescent:1||Close contact:1||Case definition:1||Adenovirus:1||SAFETY:1||Korean.:1||Travel medicine:1||Creactive protein:1||acute respiratory infections:1||Diurnal temperature range:1||seawater:1||generalized additive models:1||Southern hemisphere:1||Bayesian analysis:1||cohort study:1||Social network analysis:1||wild birds:1||Interrupted TimeSeries Analysis:1||adverse drug reactions:1||Asuncion:1||postCOVID conditions:1||intervention:1||Health Behavior:1||Path analysis model:1||generation time:1||Vaccine hesitancy:1||Trivalent:1||Pneumococcal vaccines:1||Immunization programs:1||Characteristics:1||Suicidal ideation:1||Streptococcus pneumoniae:1||Transmission:1||Postpartum center:1||Carbapenem resistance:1||Children:1||rabies:1||monclonal antibody:1||leptospirosis:1||Livestock Manure Control Policy:1||Malaria antibody test:1||Selfquarantine:1||perception:1||vaccination coverage:1||H1N1:1||Acute kidney injury:1||Acute upper respiratory tract infections:1||plasmid:1||SHV12:1||Disease hotspot:1||Baths:1||Chlorhexidine gluconate:1||Immunity:1||culling:1||habitat suitability model:1||Case Fatality Rate:1||socioeconomic:1||generalized additive model:1||acute cerebrovascular complications:1||spatiotemporal analysis:1||One Health:1||Infection preventionist:1||Occupational stress:1||New infectious disease:1||Pneumococcal conjugate vaccine:1||Population health:1||Cost of illness:1||Adult:1||Piperacillintazobactam:1||North Korea:1||prevention:1||Respiratory virus:1||Interrupted time series:1||Legionella:1||Blood donor:1||lung injury:1||epidemiologic investigation:1||Febrile respiratory illness:1||RESPONSES:1||MF59:1||prescription:1||Bioterrorism education:1||severity:1||Chronic Ear Survey:1||Hearing:1||Communicable diseases prevention act:1||Health policy evaluation:1||Travel health:1||Casecontrol studies:1||Costeffective analysis:1||Economic
evaluation:1||Competencybased education:1||Climate factors:1||temperature:1||complications:1||Spatial analyses:1||pharmacoepidemiology:1||dengue fever:1||Paraguay:1||COVID19 vaccines:1||reinfection:1||Orientia tsutsugamushi:1||Mental health:1||basic reproductive number:1||Stage 2 hypertension:1||Contact Tracing:1||Brucellosis:1||Policy:1||H5N6:1||transmission:1||Antibiotic use:1||neutralizing antibody:1||occupational exposure:1||One health:1||Zoonoses:1||Tuberculin Test:1||Delphi survey:1||Economic burden:1||septic shock:1||INFECTION:1||ANTIBODY:1||alanine aminotransferase:1||Validity.:1||History:1||Immunization program:1||GeoSentinel:1||agriculture:1||cancer:1||Nursing education:1||Undergraduate:1||coronavirus disease:1||Liver neoplasms:1||disease cluster:1||Highly pathogenic avian influenza:1||Major Depressive Disorder:1||역학조사관:1||만족도:1||retrospective cohort study:1||infectious disease:1||symptoms:1||Emerging infectious diseases:1||Reinfection:1||Cohort study:1||Pediatric immunization:1||Multilevel analysis:1||Effectiveness:1||Avian influenza:1||betaLactamase inhibitor:1||Medical Journals:1||personal protective equipment:1||Scarlet fever:1||reproducibility:1||Spatial:1||Selfisolation:1||humidifier:1||CHILDREN:1||TETANUS:1||School:1||Genotype:1||Influenzapositive proportion:1||Intensive care unit:1||Interrupted timeseries analysis:1||Varicella Zoster Virus Infection:1||Chickenpox Vaccine:1||Biosecurity:1||local transmission:1||inequality:1||SARSCoV2:1||Physical Distancing:1||machine learning:1||역량:1||.:1||ecology:1||Scrub typhus:1||Seasons:1||Mites:1||Chronic disease:1||Pandemics:1||Psychological stress:1||Health care utilisation:1||Blood pressure:1||Disease Transmission:1||Seasonal influenza:1||Costeffectiveness:1||Socioeconomic factors:1||23valent pneumococcal vaccine:1||RSV:1||Invasive pneumococcal disease:1||Medical Research:1||Timeseries analysis:1||Kindergarten:1||radiation:1||questionnaire:1||Quality:1||Infectious disease:1||blood transfusion:1||severe sepsis:1||antibacterial agent:1||Pandemic:1||Handicap:1||Program evaluation:1||Pretravel visit:1||farmers:1||Costbenefit analysis:1||Vibrio vulnificus infection:1||spread:1||Spatial analysis:1||Vancomycinresistant enterococci:1||Acquisition:1||spatial analysis:1||alopecia areata:1||transmission kernel:1||phylogenetic:1||Vibrio vulnificus:1||adverse drug reaction reporting systems:1||data mining:1||vaccination:1||Coronavirus Disease 2019:1||Severe Acute Respiratory Syndrome Coronavirus 2:1||Sex ratio:1||VectorBorne diseases:1||Climate change:1||hypertension:1||incidence:1||prehypertension:1||quarantine:1||compliance:1||Preventive medicine:1||Teaching:1||Pertussis:1||radiologic technologists:1||Standardization.:1||Tuberculosis:1||Prostatic hyperplasia:1||Priority:1||Pneumonia:1||Risk factor:1||INFLUENZAVIRUS:1||IMMUNOGENICITY:1||DIPHTHERIA:1||communityacquired pneumonia:1||Bioterrorism preparedness:1||hepatitis A virus:1||morbidity:1||Reliability:1||epidemic keratoconjunctivitis(EKC):1||acute hemorrhagic conjunctivitis(AHC):1||regional difference:1||bocaviruses:1||relative risk:1||Public health surveillance:1||DHA1:1||Gallbladder neoplasms:1||Cohort Studies:1||Heterologous:1||controlling strategy:1||spatialtemporal risk model:1||mobility:1||Kawasaki disease:1||Turnover:1||Wavelet analysis:1||

RSS_1.0 RSS_2.0 ATOM_1.0

145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE